Mode
Text Size
Log in / Sign up
N/A Completed N=90 Randomized Double-blind Treatment

Low Dose Peri- Operative Intra Venous Teranexamic Acid Reduces Blood Loss After Total Knee Arthroplasty: A Double Blind Randomized Placebo Controlled Clinical Trial

Knee Arthroplasty, Total
Source: ClinicalTrials.gov NCT02327117 ↗
Enrolled (actual)
90
Serious AEs
0.0%
Results posted
Jul 2016
Primary outcomePrimary: Hb Level 48 Hours After Total Knee Arthroplasty — 10.92; 10.23 gr/dL

Summary

Total Knee Arthroplasty (TKA) is a common orthopedic surgery usually leads to Bleeding. The null hypothesis of this study was that TA has no effect on post surgical bleeding in patients undergoes TKA.

Outcome Measures

OutcomeResultp-value
PRIMARY
Hb Level 48 Hours After Total Knee Arthroplasty
10.92; 10.23

Eligibility Criteria

Inclusion Criteria

  • Individuals with osteoarthritis who indicated for primary TKA.

Exclusion Criteria

  • Previous history of ceberovascular diseases
  • Previous history of myocardial infarction
  • Candidates for bilateral TKA
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02327117). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search